Women’s Health Market Size, Trends & Growth Opportunity By Product Type, By Application (Postmenopausal Osteoporosis, Hormonal Infertility, Menopause, and Others), By Region and Forecast till 2027
Report ID : QR10028 | Industries : Healthcare | Published On :September 2021 | Page Count : 245Global Women’s Health Market
Women’s health is the essential and important point which provides information regarding health issues of females. Women aged over 60 are suffering from various high risk diseases such as osteoporosis, anemia, menstrual health related problems, osteoarthritis, depression, and obesity to prevent and treat these diseases will increase in the demand for global women’s health market. Further, unhealthy diet and changed lifestyle will have the positive impact on global women’s health market.
Global Women’s Health Market Drivers
Rise in population of women aged over 60 is the major driving factor which is expected to boost the global women’s market growth. Furthermore, increase in government initiatives to improve women’s health and rise in awareness activities will have the positive impact on global women’s health market growth. In addition to that, rise in incidences of higher risk diseases like osteoporosis, anemia, osteoarthritis, menstrual health related disorders, obesity, and depression will improve the demand for women’s health market during this forecast period.
Know more about this report: request for sample pages
Global Women’s Health Market Restraints
However, lack of awareness and reluctance to use contraceptives are the restraining factor which is expected to hamper the global women’s health market growth.
Global Women’s Health Market Segmentation
Global Women’s Health Market is segmented into product type such as Devices (Vaginal Rings, Intra Uterine Devices, Implants, and Female Condoms), and Drugs (Menopausal Hot Flashes Drugs, and Menopause Drugs), by application such as Postmenopausal Osteoporosis, Hormonal Infertility, Menopause, and Others.
Also, Global Women’s Health Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East and Africa.
Global Women’s Health Market Key Players
Various key players are discussed in this report such as Amgen, Bayer AG, Eli Lilly and Company, Pfizer, Allergan, Novartis AG, Lupin Limited, Mylan NV,Agile Therapeutics, Allergan, Merck & Co, Johnson & Johnson Services Inc, and Ferring Pharemaceuticals.
Global Women’s Health Market Taxonomy
By Product Type
- Devices
- Vaginal Rings
- Implants
- Intra Uterine Devices
- Female Condoms
- Drugs
- Menopausal Hot Flashes Drugs
- Menopause Drugs
By Application
- Postmenopausal Osteoporosis
- Hormonal Infertility
- Menopause
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Women’s Health Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
Global Women’s Health Market
1. Executive Summary
1.1. Market Taxonomy
2. Global Women’s Health Market Demand (in Value or Size in US$ Mn) Analysis and Forecast
3. Market Background
3.1. Forecast Factor
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Challenges
3.2.3. Trends
4. Global Women’s Health Market Snapshot
5. Global Women’s Health Market Analysis, By Types
5.1. Y-o-Y Growth Comparison, By Types
5.2. Global Women’s Health Market Share Analysis, By Types
5.3. Global Women’s Health Market Size and Forecast, By Types
5.3.1 Devices
5.3.1.1 Vaginal Rings
5.3.1.2 Implants
5.3.1.3 Intra Uterine Devices
5.3.1.4 Female Condoms
5.3.2 Drugs
5.3.2.1 Menopausal Hot Flashes Drugs
5.3.2.2 Menopause Drugs
6. Global Women’s Health Market Analysis, By Application
6.1. Y-o-Y Growth Comparison, By Application
6.2. Global Women’s Health Market Share Analysis, By Application
6.3. Global Women’s Health Market Size and Forecast, By Application
6.3.1 Postmenopausal Osteoporosis
6.3.2 Hormonal Infertility
6.3.3 Menopause
6.3.4 Others
7. Global Women’s Health Market Analysis, By Region
7.1. Y-o-Y Growth Comparison, By Region
7.2. Global Women’s Health Market Share Analysis, By Region
8. North America Women’s Health Market Analysis and Forecast (2017-2027)
8.1 Introduction
8.2 North America Women’s Health Market Analysis, By Types
8.3 North America Women’s Health Market Analysis, By Application
8.4 North America Women’s Health Market Analysis, By Country
8.4.1USA
8.4.2 Canada
8.4.3 Mexico
9. Europe Women’s Health Market Analysis and Forecast (2017-2027)
9.1 Introduction
9.2 Europe Women’s Health Market Analysis, By Types
9.3 Europe Women’s Health Market Analysis, By Application
9.4 Europe Women’s Health Market Analysis, By Country
9.4 .1Germany
9.4 .2 France
9.4.3 UK
9.4 .4 Rest of Europe
10. Asia Pacific Women’s Health Market Analysis and Forecast (2017-2027)
10.1 Introduction
10.2 Asia Pacific Women’s Health Market Analysis, By Types
10.3Asia Pacific Women’s Health Market Analysis, By Application
10.4 Asia Pacific Women’s Health Market Analysis, By Country
10.4.1China
10.4.2 India
10.4.3 Japan
10.4.4 Rest of Asia Pacific
11. Latin America Women’s Health Market Analysis and Forecast (2017-2027)
11.1 Introduction
11.2 Latin America Women’s Health Market Analysis, By Types
11.3Latin America Women’s Health Market Analysis, By Application
12. Middle East & Africa Women’s Health Market Analysis and Forecast (2017-2027)
12.1 Introduction
12.2 Middle East & Africa Women’s Health Market Analysis, By Types
12.3Middle East & Africa Women’s Health Market Analysis, By Application
13. Competition Analysis
13.1 Competition Dashboard
13.2Market Share Analysis of Top Vendors
13.3 Key Development Strategies
14. Company Profiles
14.1 Amgen
14.1.1 Overview
14.1.2 Offerings
141.3 Key Financial
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Bayer AG
14.3 Eli Lilly and Company
14.4 Pfizer
14.5 Allergan
14.6 Novartis AG
14.7 Lupin Limited
14.8 Mylan NV
14.9 Agile Therapeutics
14.10 Allergan
14.11 Merck & Co
14.12 Johnson & Johnson Services Inc
14.13 Ferring Pharmaceuticals